Our safety rating, or Experience Modification Rate (EMR), is calculated by comparing our claims history and safety record to other businesses in the same industry and the same state.
At Tate, we’re proud to have maintained an extremely favorable and highly regarded low EMR, at or below .80 for the past five years. To achieve this, we devised a robust safety plan and implemented actionable steps to improve safety. We then deployed rigorous, continuous training to keep it there. We strive for the highest safety requirements at every moment.
It’s always smart to put safety first. Everyone benefits from increased hazard recognition, reduced incidents, fewer risky behaviors and enhanced operating efficiency.
In addition to this, our focus on safety has helped us decrease our insurance rates, annually lower our EMR and solidify strong partnerships with our customers that ensure the safety of their people and property. It has also generated significant operational savings, giving Tate a real market advantage over the competition.
The mechanical systems we install and maintain are not only powerfully effective, but also require powerful safety measures.
We have a rigorous safety program in place to ensure our clients (and theirs) the utmost in safety. Our comprehensive training aligns with the regulatory guidance of MOSH, VOSH, OSHA, EM 385, EPA, DOT, FMCSR and MSHA.
Safety is a steady mission. Our service teams consistently undergo cross-functional safety training to maintain up-to-date certifications, and are equipped to handle all of the various systems we offer. We also offer on-site customer training to ensure that you know the nuances of your particular mechanical system and understand its safe operation. Finally, our Quality Assurance Department consistently checks client facilities and reviews safety procedures to deliver ongoing, continuous improvement.
In order to protect our employees, as well as our customers (and theirs), we have recently put into place a number of safety precautions that combat the spread of COVID-19: